# Comparison of Safety and Efficacy of Tizanidine Hydrochloride Capsules Versus Zanaflex® (Tizanidine Hydrochloride Tablets) Taken While in the Fed State (Just After a Meal) and in the Fasted State (Before a Meal) in Patients With Moderate to Severe Spasticity.

> **NCT00047580** · PHASE3 · COMPLETED · sponsor: **Elan Pharmaceuticals** · enrollment: 120 (—)

## Conditions studied

- Multiple Sclerosis
- Muscle Spasticity
- Spinal Cord Injury
- Stroke

## Interventions

- **DRUG:** tizanidine hydrochloride capsule

## Key facts

- **NCT ID:** NCT00047580
- **Lead sponsor:** Elan Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06
- **Primary completion:** —
- **Final completion:** 2002-09
- **Target enrollment:** 120 (—)
- **Last updated:** 2015-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00047580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00047580, "Comparison of Safety and Efficacy of Tizanidine Hydrochloride Capsules Versus Zanaflex® (Tizanidine Hydrochloride Tablets) Taken While in the Fed State (Just After a Meal) and in the Fasted State (Before a Meal) in Patients With Moderate to Severe Spasticity.". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00047580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*